Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP369164.RAfQpyyVvO3wj9XOtdkCqi1XHMzd7IGw613hp5ucu-fIM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP369164.RAfQpyyVvO3wj9XOtdkCqi1XHMzd7IGw613hp5ucu-fIM130_assertion type Assertion NP369164.RAfQpyyVvO3wj9XOtdkCqi1XHMzd7IGw613hp5ucu-fIM130_head.
- NP369164.RAfQpyyVvO3wj9XOtdkCqi1XHMzd7IGw613hp5ucu-fIM130_assertion description "[We examined the pre-treatment tumour biopsies (n=40) obtained from patients with rectal adenocarcinoma (clinical International Union Against Cancer stage ll/III) who were scheduled to receive neoadjuvant 5-fluorouracil-based chemoradiotherapy for EGFR, VEGF and HIF-1 expression by quantitative real-time polymerase chain reaction.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP369164.RAfQpyyVvO3wj9XOtdkCqi1XHMzd7IGw613hp5ucu-fIM130_provenance.
- NP369164.RAfQpyyVvO3wj9XOtdkCqi1XHMzd7IGw613hp5ucu-fIM130_assertion evidence source_evidence_literature NP369164.RAfQpyyVvO3wj9XOtdkCqi1XHMzd7IGw613hp5ucu-fIM130_provenance.
- NP369164.RAfQpyyVvO3wj9XOtdkCqi1XHMzd7IGw613hp5ucu-fIM130_assertion SIO_000772 20117921 NP369164.RAfQpyyVvO3wj9XOtdkCqi1XHMzd7IGw613hp5ucu-fIM130_provenance.
- NP369164.RAfQpyyVvO3wj9XOtdkCqi1XHMzd7IGw613hp5ucu-fIM130_assertion wasDerivedFrom befree-20150227 NP369164.RAfQpyyVvO3wj9XOtdkCqi1XHMzd7IGw613hp5ucu-fIM130_provenance.
- NP369164.RAfQpyyVvO3wj9XOtdkCqi1XHMzd7IGw613hp5ucu-fIM130_assertion wasGeneratedBy ECO_0000203 NP369164.RAfQpyyVvO3wj9XOtdkCqi1XHMzd7IGw613hp5ucu-fIM130_provenance.